Model
Edge
GW Pharmaceuticals PLC
0001351288
Filing type
8-K
Filing date
May 4, 2021
Updated
May 5, 2021 ยท 11:23 AM
Copy reference
Filing
8-K
Completing Asset Acquisition or Sale, Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, Material Modifications to Rights of Security Holders, Change in Company Ownership, Changes in Board, Management or Compensation, Other Events
Exhibits
EX-99.1
Completing Asset Acquisition or Sale, Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, Material Modifications to Rights of Security Holders, Change in Company Ownership, Changes in Board, Management or Compensation, Other Events